Literature DB >> 830791

Specific binding of soluble fibrin to macrophages.

L A Sherman, J Lee.   

Abstract

Guinea pig peritoneal macrophages were demonstrated to bind selectively soluble 125I-fibrin and fibrin/fibrinogen complexes as compared with fibrinogen, fibrinogen degradation products, and fibrin degradation products. Cellular uptake was considered to be surface receptor binding on the basis of removal of bound 125I-fibrin by trypsin and because uptake occurred in the presence of metabolic inhibitors. 125I-fibrin uptake could be blocked by nonradioactive fibrin but not by IgG or immune complexes. Binding was uneffected by prior treatment with plasmin or trypsin but was calcium dependent. Only limited reversibility of binding could be demonstrated after prolonged incubation. Scatchard plots permitted an estimate of the number of bound molecules. At saturation 6.92 X 10(6) 125I-fibrin molecules were bound per cell. Similar binding of fibrin was noted in polymorphonuclear leukocytes, but not lymphocytes or fibroblasts. Soluble fibrin binding may be a host defense mechanism whereby the reticuloendothelial system can remove fibrin from the blood before the development of microthrombi.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 830791      PMCID: PMC2180591          DOI: 10.1084/jem.145.1.76

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  Macrophage activation of allogeneic lymphocyte proliferation in the guinea pig mixed leukocyte culture.

Authors:  D K Greineder; A S Rosenthal
Journal:  J Immunol       Date:  1975-05       Impact factor: 5.422

2.  IN VIVO BEHAVIOR OF I-FIBRINOGEN.

Authors:  A S McFarlane
Journal:  J Clin Invest       Date:  1963-03       Impact factor: 14.808

3.  Incorporation of fibrinogen into soluble fibrin complexes.

Authors:  E Jakobsen; B Ly; P Kierulf
Journal:  Thromb Res       Date:  1974-04       Impact factor: 3.944

4.  Cytophilic activity of IgG2 from sera of unimmunized guinea-pigs.

Authors:  R G Leslie; S Cohen
Journal:  Immunology       Date:  1974-10       Impact factor: 7.397

5.  Leukofibrinolysis.

Authors:  J H Lewis; I L Szeto; W L Bayer; D C Curiel
Journal:  Blood       Date:  1972-12       Impact factor: 22.113

6.  Plasminogen: purification from human plasma by affinity chromatography.

Authors:  D G Deutsch; E T Mertz
Journal:  Science       Date:  1970-12-04       Impact factor: 47.728

7.  Blood hypercoagulability and thrombosis.

Authors:  A P Fletcher; N Alkjaersig; J O'Brien; V G Tulevski
Journal:  Trans Assoc Am Physicians       Date:  1970

8.  The cold-insoluble globulin of human plasma. I. Purification, primary characterization, and relationship to fibrinogen and other cold-insoluble fraction components.

Authors:  M W Mosesson; R A Umfleet
Journal:  J Biol Chem       Date:  1970-11-10       Impact factor: 5.157

9.  Cross-linking of cold-insoluble globulin by fibrin-stabilizing factor.

Authors:  D F Mosher
Journal:  J Biol Chem       Date:  1975-08-25       Impact factor: 5.157

10.  Reticuloendothelial clearance of circulating fibrin in the pathogenesis of the generalized Shwartzman reaction.

Authors:  L LEE
Journal:  J Exp Med       Date:  1962-05-01       Impact factor: 14.307

View more
  21 in total

Review 1.  Natural responses to unnatural materials: A molecular mechanism for foreign body reactions.

Authors:  L Tang; J W Eaton
Journal:  Mol Med       Date:  1999-06       Impact factor: 6.354

Review 2.  Glomerular fibrin deposition and removal.

Authors:  J M Bergstein
Journal:  Pediatr Nephrol       Date:  1990-01       Impact factor: 3.714

3.  Factor Xa as an interface between coagulation and inflammation. Molecular mimicry of factor Xa association with effector cell protease receptor-1 induces acute inflammation in vivo.

Authors:  G Cirino; C Cicala; M Bucci; L Sorrentino; G Ambrosini; G DeDominicis; D C Altieri
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

4.  Binding of fibrinogen to human monocytes.

Authors:  D C Altieri; P M Mannucci; A M Capitanio
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

5.  Platelet binding in mononuclear cell preparations from peripheral blood.

Authors:  W R Williams; F Cavolina; W J Williams
Journal:  Br J Exp Pathol       Date:  1983-08

6.  Fibrin-mediated vascular injury. Identification of fibrin peptides that mediate endothelial cell retraction.

Authors:  F N Rowland; M J Donovan; P T Picciano; G D Wilner; D L Kreutzer
Journal:  Am J Pathol       Date:  1984-12       Impact factor: 4.307

7.  gamma-Glutamylamine cyclotransferase. An enzyme involved in the catabolism of epsilon-(gamma-glutamyl)lysine and other gamma-glutamylamines.

Authors:  M L Fink; J E Folk
Journal:  Mol Cell Biochem       Date:  1981-08-11       Impact factor: 3.396

8.  Immunological studies of human placentae: identification and distribution of proteins in immature chorionic villi.

Authors:  P M Johnson; W P Faulk
Journal:  Immunology       Date:  1978-06       Impact factor: 7.397

9.  Delayed-type hypersensitivity skin reactions in congenital afibrinogenemia lack fibrin deposition and induration.

Authors:  R B Colvin; M W Mosesson; H F Dvorak
Journal:  J Clin Invest       Date:  1979-06       Impact factor: 14.808

10.  Aggregation of human peripheral blood mononuclear cells by calcium ionophore A23187. Comparison with the aggregation of platelets and defective response in Glanzmann's thrombasthenia.

Authors:  A M Cerbone; G Di Minno; P Montemurro; C Iride; N Ciavarella; A Scillitani; N Semeraro
Journal:  Agents Actions       Date:  1988-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.